Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats
Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats. Pharmacognosy Magazine [Internet]. 2017;13(52):677-682. https://www.ncbi.nlm.nih.gov/pubmed/29200733
.